CymaBay Therapeutics

CymaBay Therapeutics

Developing therapies for liver and other chronic diseases with high unmet medical need. Learn more

Launch date
Employees
Market cap
CAD5.1b
Enterprise valuation
CAD4.7b (Public information from Mar 2024)
Hayward California (HQ)
Authorizing premium user...